Affinity Investment Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Affinity Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$213.86 - $277.87 $21,813 - $28,342	-102 Reduced 10.52%	868 $203,000
Q1 2022 May 05, 2022	BUY	$259.82 - $298.18 $27,021 - $31,010	104 Added 12.01%	970 $256,000
Q4 2021 Feb 04, 2022	BUY	$271.6 - $314.21 $41,011 - $47,445	151 Added 21.12%	866 $272,000
Q3 2021 Nov 08, 2021	BUY	$274.82 - $308.34 $196,496 - $220,463	715 New	715 $201,000
Q3 2018 Nov 09, 2018	SELL	$167.67 - $188.27 $2.06 Million - $2.31 Million	-12,279 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$160.33 - $189.41 $12,666 - $14,963	79 Added 0.65%	12,279 $2.2 Million
Q4 2017 Feb 07, 2018	BUY	$147.99 - $163.95 $8,879 - $9,837	60 Added 0.49%	12,200 $1.95 Million
Q3 2017 Oct 31, 2017	BUY	$149.47 - $160.56 $1.81 Million - $1.95 Million	12,140	12,140 $1.83 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.